Inhibrx Biosciences, Inc. (INBX)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
124. 66
-2.04
-1.6101%
$
1.81B Market Cap
- P/E Ratio
- Div Yield
275,588 Volume
-4.39 Eps
$ 126.7
Previous Close 
Want to track INBX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
INBX Earnings Reports FAQ
What is the earnings per share (EPS) for INBX?
The current EPS is -4.39.
What is the company's earnings growth rate?
Inhibrx Biosciences, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Inhibrx Biosciences, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Inhibrx Biosciences, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for INBX at this time, as Inhibrx Biosciences, Inc has no recent EPS data to calculate it.
